AzTrials
AzTrials

Obesity, MorbidNCT06033690

Intervention in the Surgical Treatment of Obesity

A study testing multidisciplinary guide in people with Obesity, Morbid, run by Instituto de Cardiologia do Rio Grande do Sul at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The worldwide prevalence of obesity reaching epidemic levels, and directly associated with several non-communicable chronic diseases, being considered the sixth leading cause of death in the world. In Brazil, estimated that one third of the population is overweight. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Obesity, Morbid
What is being tested?
multidisciplinary guide
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteBrazil
Study dates
8 Aug 2021to 31 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Referred for bariatric surgery Having or not comorbidity associated with obesity.

Who cannot join

  • not signing the informed consent form.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Izabele Vian

    Porto Alegre, Rio Grande do Sul, 91000000

Other trials in Brazil

About this study

Official title: Intervention Beyond Multidisciplinarity in the Surgical Treatment of Obesity Randomized Clinical Trial

The worldwide prevalence of obesity reaching epidemic levels, and directly associated with several non-communicable chronic diseases, being considered the sixth leading cause of death in the world. In Brazil, estimated that one third of the population is overweight. Currently, bariatric surgery the fastest and most effective method to control the disease. However, most patients do not follow the postoperative follow-up protocol, causing weight regain. Intervention in the literature that goes beyond multidisciplinary and can prevent weight relapse. The develop and apply an interdisciplinary manual, based on the guidelines of the Food Guide for the Brazilian Population, as a support in the prophylactic treatment of weight relapse patients and bariatric surgery

Read the detailed description

The objective of this randomized clinical study is to compare the eating behavior of obese participants who underwent the dietary guide after bariatric surgery treatment. The main questions are:

  • Can an interdisciplinary intervention through a dietary guide promote a change in eating behavior in participants undergoing surgical treatment for obesity?
  • Participants will participate in consultations and receive a food guidance guide and lectures with guidance.
  • Researchers will compare intervention and control groups to see if there will be changes in eating behavior
Conditions
Obesity, Morbid
Being tested
multidisciplinary guide
Keywords
obesity, bariatric surgery, food guide, interdisciplinarity
Medical subject headings
Obesity, Morbid, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • multidisciplinary guideBehavioural

    use of the food guide for education, clarification of doubts

Study groups in NCT06033690
Study groupRoleWhat they receive
multidisciplinary guideExperimentalConsultation and multidisciplinary guide with guidance on physical activity and healthy eating.
Receives: Behavioral: multidisciplinary guide
ControlNo interventionConsultations with a multidisciplinary team

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. behavior

    participants' scores in a pre- and post-intervention food assessment questionnaire

    Measured: 40 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2023
  2. Study start8 Aug 2021
  3. Primary completion12 Dec 2021
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06033690
Sponsor's protocol ID
UP5815/20
Status last verified
Aug 2023
First submitted
21 Jun 2023
Last updated
13 Sep 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing multidisciplinary guide in people with Obesity, Morbid, run by Instituto de Cardiologia do Rio Grande do Sul at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

behavior (time frame: 40 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in